The effect of route of immunization on mucosal immunity and protection

Journal of Infectious Diseases

Volumn 179, Issue SUPPL. 3, 1999, Pages

  Lehner, Thomas ^a,b,c   Wang, Yufei ^a,b,c   Ping, Louisa ^a,b,c   Bergmeier, Lesley ^a,b,c   Mitchell, Elaine ^a,b,c   Cranage, Martin ^a,b,c   Hall, Graham ^a,b,c   Dennis, Mike ^a,b,c   Cook, Nicola ^a,b,c   Doyle, Carl ^a,b,c   Jones, Ian ^a,b,c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c Institute of Virology   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; GLYCOPROTEIN GP 120; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; PROTEIN P27; RANTES; SECRETORY IMMUNOGLOBULIN; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; HELPER CELL; ILEUM MUCOSA; IMMUNE RESPONSE; IMMUNIZATION; INTESTINE INFECTION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; INTRAVAGINAL DRUG ADMINISTRATION; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MACACA; MALE; MUCOSAL IMMUNITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECTAL DRUG ADMINISTRATION; RECTUM MUCOSA; SIMIAN IMMUNODEFICIENCY VIRUS; SUPPRESSOR CELL; VIRUS INFECTION; VIRUS LOAD;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINES; CYTOTOXICITY, IMMUNOLOGIC; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, MUCOSAL; IMMUNIZATION; INTESTINAL MUCOSA; LYMPH NODES;

EID: 0032920075     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314809     Document Type: Conference Paper

References (19)

1. 1. McDermott MR, Bienenstock J. Evidence for a common immunologic mucosal system. I. Migration of B immunoblasts into intestinal, respiratory and genital tissues. J Immunol 1979;122:1892-8.
2. 2. Wira CR, Sandoe CP. Specific IgA and IgG antibodies in the secretions of the female reproductive tract: effects of immunization and estradiol on expression of this response in vivo. J Immunol 1987;138:4159-64.
3. 3. Lehner T, Panagiotidi C, Bergmeier LA, Tao L, Brookes R, Adams S. A comparison of the immune responses following oral, vaginal or rectal route of immunization with SIV antigens in non-human primates. Vaccine Res 1992;1:319-30.
4. 4. Marx PA, Compans RW, Getie A, et al. Protection against vaginal SIV transmission with microencapsulated vaccine. Science 1993;260:1323-7.
5. 5. Lehner T, Bergmeier LA, Panagiotidi C, et al. Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein. Science 1992;258:1365-9.
6. 6. Lehner T, Tao L, Panagiotidi C, et al. Mucosal model of genital immunization in male rhesus macaques with a recombinant simian immunodeficiency virus p27 antigen. J Virol 1994;68:1624-32.
7. 7. Lehner T, Brookes R, Panagiotidi C, et al. T and B cell functions and epitope expression in non-human primates immunized with SIV by the rectal route. Proc Natl Acad Sci USA 1993;90:8638-42.
8. 8. Lehner T, Bergmeier LA, Tao L, et al. Targeted lymph node immunization with simian immunodeficiency virus p27 antigen to elicit genital, rectal and urinary immune responses in nonhuman primates. J Immunol 1994;153:1858-68.
9. 9. Pantaleo G, Graziosi C, Demarest JF, et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993;362:355-7.
10. 10. Armstrong JA, Horne R. Follicular dendritic cells and virus-like particles in AIDS-related lymphadenopathy. Lancet 1984;2:370-2.
11. 111 expression in infected lymph nodes and relevance to pathogenesis of lymphadenopathy. Am J Pathol 1986;125:436-42.
12. 12. Lehner T, Wang Y, Cranage M, et al. Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nat Med 1996;2:767-75.
13. 13. Doyle CB, Bhattacharyya U, Kent KA, Stott JE, Jones IM. Regions required for CD4 binding in the external glycoprotein gp120 of simian immunodeficiency virus. J Virol 1995;69:1256-60.
14. 14. Rud EW, Cranage M, Yon J, et al. Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants. J Gen Virol 1994;75:529-43.
15. + cell antiviral factor. Cell Immunol 1994;153:329-43.
16. 16. Amara A, Le Gall S, Schwartz O, et al. HIV coreceptor downregulation as antiviral principle: SDF-1α-dependent internalization of the chemokine receptor CXCR4 contributes to HIV replication. J Exp Med 1997;186: 139-46.
17. 17. Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 co-receptor accounts for resistance of some multiply-exposed individuals to HIV infection. Cell 1996;86:367-77.
18. 18. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR5 chemokine receptor gene. Nature 1996;382:722-5.
19. 19. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIVinfection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996;273:1856-62.